3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Carcinoma, Ovarian Epithelial
5
Ovarian Neoplasms
4
Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Sarcoma, Endometrial Stromal
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rhabdomyosarcoma
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Neurofibrosarcoma
1
Melanoma
1
Malignant mesenchymal tumor
1
Lung Neoplasms
1
Liver Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Fibrosarcoma
1
Fallopian Tube Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
pembrolizumab
18
Nivolumab
7
Carboplatin
7
durvalumab
5
Ipilimumab
5
aldesleukin
4
Paclitaxel
4
Irinotecan
4
Gemcitabine
4
Docetaxel
4
Cisplatin
4
sargramostim
3
atezolizumab
3
Topotecan
3
Polymerase Chain Reaction
3
Magnetic Resonance Spectroscopy
3
temsirolimus
2
talazoparib
2
carfilzomib
2
cabozantinib
2
budigalimab
2
Trastuzumab
2
Therapeutics
2
Taxes
2
Specimen Handling
2
Psychiatric Rehabilitation
2
Injections
2
Gene Expression Profiling
2
Fulvestrant
2
Fluorodeoxyglucose F18
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Mass Spectrometry
×
Gynecologic
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled